Trial intelligence / Profile preview

Docetaxel-based adjuvant chemotherapy in stage IB-II NSCLC

NCT00434668Phase 2Completed

Start
Dec 2005
Primary completion
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of docetaxel in non-small cell lung cancer (NSCLC). Started Dec 2005; status: completed.

02

Drugs

docetaxel
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT00434668.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00434668.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call